Increased risk of end-stage renal disease in individuals with coeliac disease

Gut

Volumn 61, Issue 1, 2012, Pages 64-68

  Welander, Adina ^a   Prütz, Karl Göran ^b   Fored, Michael ^a   Ludvigsson, Jonas F ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CELIAC DISEASE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HOSPITAL DEPARTMENT; HUMAN; HUMAN TISSUE; INFANT; INTESTINE BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK FACTOR; SCHOOL CHILD; SEX DETERMINATION; SWEDEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INTESTINE, SMALL; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RISK; YOUNG ADULT;

EID: 83555176417     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300134     Document Type: Article

References (45)

1. Rubio-Tapia A, Murray JA. Celiac disease. Curr Opin Gastroenterol 2010;26:116-22.
2. Maki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517-24. (Pubitemid 36706539)
3. Dube C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005;128:S57-67. (Pubitemid 40460823)
4. Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-43.
5. Askling J, Linet M, Gridley G, et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002;123:1428-35. (Pubitemid 35231641)
6. Collin P, Reunala T, Pukkala E, et al. Coeliac diseasedassociated disorders and survival. Gut 1994;35:1215-18.
7. Elfstrom P, Montgomery SM, Kampe O, et al. Risk of primary adrenal insufficiency in patients with celiac disease. J Clin Endocrinol Metab 2007;92:3595-8. (Pubitemid 47435340)
8. Hsu CY, Vittinghoff E, Lin F, et al. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 2004;141:95-101.
9. Muntner P, Coresh J, Powe NR, et al. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol 2003;14:1568-77. (Pubitemid 36687058)
10. Swedish Renal Registry. Active uraemia care in Sweden 1991-2009, 2010. http://www.medscinet.net/snr/rapporterdocs/AKTIV%20UREMIVA° RD%20I%20SVERIGE%201991%20-%202009.pdf (accessed 1 May 2011).
11. Rostoker G, Terzidis H, Petit-Phar M, et al. Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis. Clin Exp Immunol 1992;90:305-11.
12. Rostoker G, Delchier JC, Chaumette MT. Increased intestinal intra-epithelial T lymphocytes in primary glomerulonephritis: a role of oral tolerance breakdown in the pathophysiology of human primary glomerulonephritides? Nephrol Dial Transplant 2001;16:513-17. (Pubitemid 32229282)
13. Kovacs T, Kun L, Schmelczer M, et al. Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability. Am J Nephrol 1996;16:500-5. (Pubitemid 26387935)
14. Coppo R, Camilla R, Amore A, et al. Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy. Clin Exp Immunol 2010;159:73-81.
15. Pierucci A, Fofi C, Bartoli B, et al. Antiendomysial antibodies in Berger's disease. Am J Kidney Dis 2002;39:1176-82. (Pubitemid 34591932)
16. Ots M, Uibo O, Metskula K, et al. IgA-antigliadin antibodies in patients with IgA nephropathy: the secondary phenomenon? Am J Nephrol 1999;19:453-8. (Pubitemid 29397072)
17. Ferri C, Puccini R, Longombardo G, et al. Low-antigen-content diet in the treatment of patients with IgA nephropathy. Nephrol Dial Transplant 1993;8:1193-8. (Pubitemid 23342650)
18. Collin P, Syrjanen J, Partanen J, et al. Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol 2002;97:2572-6.
19. Ludvigsson JF, Montgomery SM, Olen O, et al. Coeliac disease and risk of renal diseaseda general population cohort study. Nephrol Dial Transplant 2006;21:1809-15. (Pubitemid 43985707)
20. Peters U, Askling J, Gridley G, et al. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003;163:1566-72. (Pubitemid 36835101)
21. Ludvigsson JF, Montgomery SM, Ekbom A, et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009;302:1171-8.
22. Schon S, Ekberg H, Wikstrom B, et al. Renal replacement therapy in Sweden. Scand J Urol Nephrol 2004;38:332-9. (Pubitemid 39277294)
23. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983;32 Suppl 2:64-78. (Pubitemid 13099685)
24. Sollid LM, Markussen G, Ek J, et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345-50. (Pubitemid 19035567)
25. Johannesson I. The Total Population Register of Statistics Sweden: New Possibilities and Better Quality. Örebro: Statistics Sweden, 2002.
26. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659-67.
27. Ludvigsson JF, Brandt L, Montgomery SM, et al. Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterol 2009;9:19.
28. Lie BA, Sollid LM, Ascher H, et al. A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens 1999;54:162-8. (Pubitemid 29410774)
29. Linnersjo A, Hammar N, Gustavsson A, et al. Recent time trends in acute myocardial infarction in Stockholm, Sweden. Int J Cardiol 2000;76:17-21.
30. Lichtenstein P, Bjork C, Hultman CM, et al. Recurrence risks for schizophrenia in a Swedish national cohort. Psychol Med 2006;36:1417-25. (Pubitemid 44355977)
31. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 1999;38:668-74. (Pubitemid 29507338)
32. Snook JA, Dwyer L, Lee-Elliott C, et al. Adult coeliac disease and cigarette smoking. Gut 1996;39:60-2. (Pubitemid 26239106)
33. Suman S, Williams EJ, Thomas PW, et al. Is the risk of adult coeliac disease causally related to cigarette exposure? Eur J Gastroenterol Hepatol 2003;15:995-1000. (Pubitemid 37094299)
34. Orth SR. Smokingda risk factor for progression of renal disease. Kidney Blood Press Res 2000;23:202-4.
35. Rossing P, Hougaard P, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 2002;25:859-64. (Pubitemid 41094283)
36. Walker MM, Murray JA, Ronkainen J, et al. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a populationbased study. Gastroenterology 2010;139:112-19.
37. Hogg RJ, Silva FG, Wyatt RJ, et al. Prognostic indicators in children with IgA nephropathydreport of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 1994;8:15-20. (Pubitemid 24042359)
38. Ibels LS, Gyory AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994;73:79-102. (Pubitemid 24114627)
39. Fennessy M, Hitman GA, Moore RH, et al. HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations. Kidney Int 1996;49:477-80. (Pubitemid 26051831)
40. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002;347:738-48. (Pubitemid 35203906)
41. Fornasieri A, Sinico RA, Maldifassi P, et al. IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease). Br Med J (Clin Res Ed) 1987;295:78-80. (Pubitemid 17096077)
42. Sategna-Guidetti C, Ferfoglia G, Bruno M, et al. Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy? Gut 1992;33:476-8.
43. Huang MC, Chen ME, Hung HC, et al. Inadequate energy and excess protein intakes may be associated with worsening renal function in chronic kidney disease. J Ren Nutr 2008;18:187-94.
44. Bernstein AM, Treyzon L, Li Z. Are high-protein, vegetable-based diets safe for kidney function? A review of the literature. J Am Diet Assoc 2007;107:644-50. (Pubitemid 46440662)
45. Stevens PE, O'Donoghue DJ, de Lusignan S, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007;72:92-9. (Pubitemid 47014451)